Published in Eur J Gastroenterol Hepatol on December 01, 1996
The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07
Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut (1998) 2.14
Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut (2002) 2.13
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut (2005) 1.29
Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci (2006) 1.19
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therap Adv Gastroenterol (2011) 0.92
Mesalazine in inflammatory bowel disease: a trendy topic once again? Can J Gastroenterol (2010) 0.92
Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature. World J Gastroenterol (2006) 0.90
5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol (2005) 0.90
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol (2014) 0.88
5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis. PLoS One (2014) 0.87
Emerging drugs for the treatment of ulcerative colitis. Expert Opin Emerg Drugs (2009) 0.87
Mesalamine protects against colorectal cancer in inflammatory bowel disease. Dig Dis Sci (2009) 0.86
Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis (2003) 0.85
A case of small bowel adenocarcinoma in a patient with Crohn's disease detected by PET/CT and double-balloon enteroscopy. World J Gastroenterol (2009) 0.85
Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? World J Gastroenterol (2006) 0.82
5-aminosalicylic acid in combination with nimesulide inhibits proliferation of colon carcinoma cells in vitro. World J Gastroenterol (2007) 0.79
Adherence in ulcerative colitis: an overview. Patient Prefer Adherence (2017) 0.79
Does patient knowledge affect the colorectal cancer risk in ulcerative colitis? Postgrad Med J (2002) 0.78
Distal adenomatous polyps are rare in patients with inflammatory bowel disease. Postgrad Med J (2006) 0.77
Chemopreventive effects of 5-amino salicylic acids on inflammatory bowel disease-associated colonic cancer and colonic dysplasia: a meta-analysis. Int J Clin Exp Med (2015) 0.77
Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain. World J Gastroenterol (2013) 0.77
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol (2016) 0.77
Overcoming adherence issues in ulcerative colitis. Gastroenterol Hepatol (N Y) (2007) 0.76
Duration of treatment with 5-aminosalicylic acid compounds. World J Gastroenterol (2007) 0.76
Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia. Mol Pharmacol (2009) 0.76
Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial. Patient Prefer Adherence (2008) 0.76
Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Oncotarget (2016) 0.75
Current practice and clinicians' perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians. World J Gastrointest Pharmacol Ther (2017) 0.75
Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats. Therap Adv Gastroenterol (2010) 0.75
The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07
Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol (2008) 2.61
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc (2000) 2.42
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut (2005) 2.36
Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut (2002) 2.13
Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05
Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04
Patients' views on how to run hospital outpatient clinics. J R Soc Med (1991) 2.03
Mucins in the gastrointestinal tract in health and disease. Front Biosci (2001) 1.99
Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut (1992) 1.96
Risk factors for esophageal cancer in Coimbatore, southern India: a hospital-based case-control study. Indian J Gastroenterol (2004) 1.93
Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg (1988) 1.91
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut (1986) 1.86
The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. Am J Gastroenterol (1999) 1.74
Meta-analysis: mortality in Crohn's disease. Aliment Pharmacol Ther (2007) 1.73
Liver biopsy under ultrasound control: implications for training in the Calman era. Gut (1999) 1.70
Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.69
Studies of incidence and prevalence of achalasia in the Nottingham area. Q J Med (1985) 1.64
Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut (1986) 1.63
Mortality in Crohn's disease. Q J Med (1980) 1.62
Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60
Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med (1992) 1.56
Life insurance and inflammatory bowel disease: is there discrimination against patients? Int J Colorectal Dis (1996) 1.54
Review article: cytomegalovirus and inflammatory bowel disease. Aliment Pharmacol Ther (2015) 1.54
The compulsory removal of elderly people in England and Wales under Section 47 of the National Assistance Act and its 1951 Amendment: a survey of its implementation in England and Wales in 1988 and 1989. Age Ageing (1995) 1.52
Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol (2011) 1.49
Membranotomy for Budd-Chiari syndrome. Ann Thorac Surg (1990) 1.49
What the patient wants to know about Crohn's disease. J Clin Gastroenterol (1983) 1.48
An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol (1999) 1.46
Smoking and prevention. Respir Med (1991) 1.42
An audit of Crohn's disease in a defined population. J R Coll Physicians Lond (1983) 1.42
Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Aliment Pharmacol Ther (2013) 1.41
The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.41
Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41
Issues of consent in colonoscopy: if a patient says 'stop' should we continue? J R Soc Med (1999) 1.39
Elderly people at home who cannot cope. Lancet (1991) 1.39
A study of swallowing difficulties in first degree relatives of patients with achalasia. Thorax (1985) 1.38
A nationwide survey of liver biopsy--is there a need to increase resources, manpower and training? Hepatogastroenterology (1994) 1.38
Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36
Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther (2007) 1.35
Mucins and inflammatory bowel disease. Postgrad Med J (2000) 1.34
The practice of rectal examination. Postgrad Med J (1991) 1.34
The gastroenterology service: a survey of general practitioners' requirements. J R Soc Med (1993) 1.33
The role of acupuncture in the treatment of irritable bowel syndrome: a pilot study. Hepatogastroenterology (1997) 1.31
Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29
Some aspects of the epidemiology of ulcerative colitis. Gut (1985) 1.28
Measles, month of birth, and Crohn's disease. Gut (2000) 1.26
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26
Oral submucosal fibrosis--a preventable disease. Gut (1992) 1.24
Epidemiology of proctocolitis in the region of Leiden, The Netherlands. A population study from 1979 to 1983. Scand J Gastroenterol (1987) 1.23
Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23
Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation. J Clin Gastroenterol (2007) 1.21
The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol (1999) 1.20
Screening: the legal view. Public Health (2001) 1.19
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Epidemiology of Crohn's disease in Regio Leiden, The Netherlands. A population study from 1979 to 1983. Gastroenterology (1987) 1.17
Achalasia following gastro-oesophageal reflux. J R Soc Med (1986) 1.17
Female fertility, obstetric and gynaecological history in coeliac disease. A case control study. Digestion (1994) 1.16
Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci (1998) 1.15
Mortality in acute upper gastrointestinal haemorrhage: a six-year survey from the University Hospital of Wales. Postgrad Med J (1981) 1.15
An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn's disease, ulcerative colitis and control subjects. Digestion (1983) 1.14
Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci (1981) 1.13
Are we telling patients enough? A pilot study to assess patient information needs in a gastroenterology outpatient department. Eur J Gastroenterol Hepatol (1998) 1.10
The attitude of employers to people with inflammatory bowel disease. Soc Sci Med (1992) 1.09
Inflammatory bowel disease in the rural Indian subcontinent: a survey of patients attending mission hospitals. Digestion (1990) 1.08
Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes. Gut (1998) 1.08
Towards better informed consent in endoscopy: a study of information and consent processes in gastroscopy and flexible sigmoidoscopy. Eur J Gastroenterol Hepatol (2001) 1.08
Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study. Gut (1992) 1.07
Epidemiological study of abdominal tuberculosis among Indian migrants and the indigenous population of Leicester, 1972-1989. Gut (1992) 1.06
Genotype phenotype correlation in Wilson's disease within families--a report on four south Indian families. World J Gastroenterol (2008) 1.06
Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion (1993) 1.05
Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study. Dig Dis Sci (1993) 1.04
Choice of therapy for achalasia in relation to age. Digestion (1988) 1.04
A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry. J Breath Res (2008) 1.04
Evidence of T cell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol (1999) 1.03
The role of local self-help groups for patients with inflammatory bowel disease. Int J Colorectal Dis (1987) 1.03
Does Crohn's disease need differentiation from tuberculosis? J Gastroenterol Hepatol (1996) 1.02
Xanthelasma of esophagus and stomach. Indian J Gastroenterol (2000) 1.02